NIH-funded research NIH-funded research

Investigating how edelfosine affects gut bacteria after seizures

Official title: Determining the Impact of Edelfosine on Restoring the Gut Microbiota after and Epileptic Insult

Funded at University of Puerto Rico Med Sciences · NIH-11019163 · Data updated 2026-11-12

This study is looking at how the drug edelfosine might help improve gut health in people who have had seizures by restoring the balance of good bacteria in their stomachs.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Puerto Rico Med Sciences
NIH-funded
Lab location1 site (San Juan, United States)
Project startMay 15, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$316,179
NIH project number1P20GM156713-01
Project IDNIH-11019163 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with epilepsy who are experiencing disruptions in their gut microbiota.

Less likely to help

Patients who do not have epilepsy or those who are not affected by gut microbiota imbalances may not benefit from this research.

What this research studies

This research explores the effects of edelfosine, a drug, on the gut microbiota in patients who have experienced seizures. It aims to understand how this drug can help restore the balance of gut bacteria that may be disrupted after an epileptic event. By analyzing fecal samples from both healthy and seizure-affected animals, the study will assess changes in gut microbiota and metabolites over time. The goal is to determine if edelfosine can create a healthier gut environment, potentially leading to better seizure management.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for epilepsy by restoring gut health and reducing seizure frequency.

How similar studies have gone: Previous research has shown promising results in modulating gut microbiota to improve epilepsy outcomes, suggesting that this approach may be effective.

Where this research is happening

  • University of Puerto Rico Med Sciences
    San Juan, United States
    Active

Researchers

  • Principal investigator: Ferrer-Acosta, Yancy — University of Puerto Rico Med Sciences
  • Study coordinator: Ferrer-Acosta, Yancy

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.